miR-137 inhibits melanoma cell proliferation through downregulation of GLO1
Late-stage melanoma is refractory to current therapies. MicroRNAs (miRNAs) can modulate many physiological and pathological processes of melanoma. Studies have demonstrated that miR-137 acts as a tumor suppressor by inhibiting the proliferation of melanoma cells through targeting multiple mRNAs. The...
Saved in:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
02 January 2018
|
| In: |
Science China. Life sciences
Year: 2018, Volume: 61, Issue: 5, Pages: 541-549 |
| ISSN: | 1869-1889 |
| DOI: | 10.1007/s11427-017-9138-9 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/s11427-017-9138-9 |
| Author Notes: | Na Lv, Shuai Hao, Chonglin Luo, Alia Abukiwan, Ying Hao, Fei Gai, Weiwei Huang, Lingyun Huang, Xueyuan Xiao, Stefan B. Eichmüller, Dacheng He |
| Summary: | Late-stage melanoma is refractory to current therapies. MicroRNAs (miRNAs) can modulate many physiological and pathological processes of melanoma. Studies have demonstrated that miR-137 acts as a tumor suppressor by inhibiting the proliferation of melanoma cells through targeting multiple mRNAs. The glyoxalase system member glyoxalase 1 (GLO1) is the principal scavenging enzyme of methylglyoxal (MG), a toxic byproduct of glycolysis. Using 35S in vivo/vitro labelling analysis for dynamic proteomics (SiLAD), we found that miR-137 downregulated the expression of GLO1 in melanoma cells. Bioinformatics analysis predicted that GLO1 is a direct target of miR-137. This was validated by dual luciferase reporter assay. Quantitative RT-PCR (qRT-PCR) and western blot analysis indicated that miR-137 could decrease endogenous GLO1 expression. Furthermore, siRNA targeting of GLO1 mimicked inhibition of melanoma cell proliferation caused by miR-137 overexpression. Re-expression of GLO1 was able to restore miR-137-mediated suppression of melanoma cell proliferation. Therefore, these results suggest that miR-137 inhibits the proliferation of melanoma cells by targeting GLO1. |
|---|---|
| Item Description: | Gesehen am 06.05.2021 |
| Physical Description: | Online Resource |
| ISSN: | 1869-1889 |
| DOI: | 10.1007/s11427-017-9138-9 |